GCC2 promotes non-small cell lung cancer progression by maintaining Golgi apparatus integrity and stimulating EGFR signaling pathways
Authors:
Open Access
- 22 November 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Abstract
Fundamental changes in intracellular processes, such as overactive growth signaling pathways, are common in carcinomas and are targets of many cancer therapeutics. GRIP and coiled-coil containing 2 (GCC2) is a trans-Golgi network (TGN) golgin maintaining Golgi apparatus structure and regulating vesicle transport. Here, we found an aberrant overexpression of GCC2 in non-small cell lung cancer (NSCLC) and conducted shRNA-mediated gene knockdown to investigate the role of GCC2 in NSCLC progression. shRNA-mediated GCC2 knockdown suppressed NSCLC cell growth, migration, stemness, and epithelial-mesenchymal transition (EMT) in vitro and tumor growth in vivo. In addition, GCC2 knockdown suppressed cancer cell exosome secretion and the oncogenic capacity of cancer cell-derived exosomes. Mechanistically, GCC2 inhibition decreased epidermal growth factor receptor (EGFR) expression and downstream growth and proliferation signaling. Furthermore, GCC2 inhibition compromised Golgi structural integrity in cancer cells, indicating a functional role of GCC2 in regulating intracellular trafficking and signaling to promote lung cancer progression. Together, these findings suggest GCC2 as a potential therapeutic target for the treatment of NSCLC.Keywords
All Related Versions
Funding Information
- Ministry of Science and ICT, South Korea (2019M3E5D5065399, 2019M3E5D5065399, 2019M3E5D5065399, 2019M3E5D5065399, 2019M3E5D5065399)
- National Research Foundation of Korea (NRF-2020R1A2C1101294, NRF-2020R1A2C1101294, NRF-2020R1A2C1101294, NRF-2020R1A2C1101294, NRF-2020R1A2C1101294)
- Ministry of Health and Welfare (RS-2022-00060247, RS-2022-00060247, RS-2022-00060247, RS-2022-00060247, RS-2022-00060247)
This publication has 62 references indexed in Scilit:
- Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated OncogenesisClinical Cancer Research, 2010
- Rab27a and Rab27b control different steps of the exosome secretion pathwayNature Cell Biology, 2009
- GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancerNature, 2009
- Multiple Rab GTPase Binding Sites in GCC185 Suggest a Model for Vesicle Tethering at theTrans-GolgiMolecular Biology of the Cell, 2009
- Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene ExpressionCancer Research, 2007
- The trans‐Golgi Network Golgin, GCC185, is Required for Endosome‐to‐Golgi Transport and Maintenance of Golgi StructureTraffic, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformationLung Cancer, 2007
- A Functional Role for the GCC185 Golgin in Mannose 6-Phosphate Receptor RecyclingMolecular Biology of the Cell, 2006
- Involvement of the Activation Loop of ERK in the Detachment from Cytosolic AnchoringJournal of Biological Chemistry, 2001